Article Details

Olaparib by AstraZeneca for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

Retrieved on: 2023-10-27 23:15:17

Tags for this article:

Click the tags to see associated articles and topics

Olaparib by AstraZeneca for Diffuse Large B-Cell Lymphoma: Likelihood of Approval. View article details on hiswai:

Excerpt

AstraZeneca is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up